000 | 01908 a2200457 4500 | ||
---|---|---|---|
005 | 20250518025219.0 | ||
264 | 0 | _c20200612 | |
008 | 202006s 0 0 eng d | ||
022 | _a1536-5166 | ||
024 | 7 |
_a10.1097/WNO.0000000000000760 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhan, Reas S | |
245 | 0 | 0 |
_aEffects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection. _h[electronic resource] |
260 |
_bJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society _c06 2019 |
||
300 |
_a191-199 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAdministration, Intranasal |
650 | 0 | 4 | _aAmnion |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Survival _xphysiology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xphysiopathology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMultipotent Stem Cells _xmetabolism |
650 | 0 | 4 |
_aNeuroprotection _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xmetabolism |
650 | 0 | 4 |
_aNystagmus, Optokinetic _xphysiology |
650 | 0 | 4 |
_aOptic Neuritis _xphysiopathology |
650 | 0 | 4 |
_aRetinal Diseases _xphysiopathology |
650 | 0 | 4 |
_aRetinal Ganglion Cells _xdrug effects |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
700 | 1 | _aDine, Kimberly | |
700 | 1 | _aWessel, Howard | |
700 | 1 | _aBrown, Larry | |
700 | 1 | _aShindler, Kenneth S | |
773 | 0 |
_tJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society _gvol. 39 _gno. 2 _gp. 191-199 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNO.0000000000000760 _zAvailable from publisher's website |
999 |
_c29437001 _d29437001 |